Home  /  Resource Library  /  Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies

Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies

Meta-analysis investigated ibrutinib for treatment of relapsed CLL.